With NightWatch, LivAssured from Geldermalsen developed a groundbreaking detection system for nocturnal seizures. The NightWatch eases the care task of parents and care professionals by giving a warning in the event of a violent night epilepsy attack. This means that help can be provided quickly and adequately, which reduces the risk of medical complications. The system was developed in collaboration with neurologists and the Epilepsy Fund.

‘We can set the next steps with the knowledge and capital of Holland Capital. With this investor, LivAssured gets a strong partner with experience in the healthcare sector and enable us to further develop the NightWatch and achieve our international growth ambitions.’

Jeroen van den Hout

CEO, LivAssured




Finance en verzekeringen


Investment period:

September 2018


Transaction type:

Growth Capital